Education
About Us
Working with TipRanks
Follow Us
XHS - AI Analysis
Top Page
SPDR S&P Health Care Services ETF (XHS)
Rating:67Neutral
Price Target:
$113.00
Positive Factors
Strong Recent Performance
The ETF has delivered solid returns over the past three months and year-to-date, indicating positive momentum.
Focused Sector Exposure
The fund’s heavy allocation to the Health Care sector provides targeted exposure to a resilient and essential industry.
Reasonable Expense Ratio
The ETF charges a relatively low expense ratio, making it cost-effective compared to actively managed funds.
Negative Factors
Underperforming Top Holdings
Several of the largest positions, such as NeoGenomics and Acadia Healthcare, have struggled with weak year-to-date performance.
High Sector Concentration
With over 96% of assets in Health Care, the fund is highly exposed to risks specific to this sector.
Limited Geographic Diversification
The ETF is almost entirely focused on U.S. companies, leaving investors vulnerable to domestic market fluctuations.
XHS vs. SPDR S&P 500 ETF (SPY)
AUM79.25M
RegionNorth America
Expense Ratio0.35%
Beta0.65
IssuerSPDR
Inception DateSep 28, 2011
Dividend Yield0.24%
Asset ClassEquity
Index TrackedS&P Health Care Services Select Industry
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10,769
30 Day Avg. Volume5,423
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
122.06Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering63
XHS Summary
The SPDR S&P Health Care Services ETF (XHS) focuses on companies in the health care sector, specifically Health Care Providers & Services. It includes businesses like hospitals, outpatient services, and managed health care. Some well-known companies in this ETF are CVS Health and McKesson. This ETF might appeal to investors looking for growth and stability, as health care is a fundamental need and demand is expected to rise with an aging population. However, new investors should be aware that the ETF’s performance can fluctuate with changes in the health care industry, such as regulatory shifts or market trends.
How much will it cost me?The SPDR S&P Health Care Services ETF (XHS) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which typically requires more active management compared to broad-market index funds.
What would affect this ETF?The SPDR S&P Health Care Services ETF (XHS) could benefit from increasing demand for health care services driven by an aging population and advancements in medical technology, which support innovation and growth in its top holdings like NeoGenomics and Guardant Health. However, potential risks include regulatory changes or shifts in government health care policies that could impact profitability, as well as broader economic conditions that may affect consumer spending on health care services. With its strong focus on U.S.-based health care providers, the ETF is well-positioned to capitalize on the sector's resilience but remains sensitive to policy and economic fluctuations.
XHS Top 10 Holdings
The SPDR S&P Health Care Services ETF (XHS) is leaning heavily into the U.S. health care sector, with a focus on providers and services. CVS Health and McKesson are steady performers, buoyed by solid earnings and operational growth, while Guardant Health is rising on improved margins and revenue momentum. However, names like Acadia Healthcare and Centene are lagging due to profitability and operational challenges. With nearly all its holdings rooted in health care, the fund’s concentration in this essential sector offers resilience, though mixed stock performance may temper short-term gains.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Clover Health Investments | 2.35% | $1.86M | $1.93B | -7.16% | 50 Neutral | |
| Guardant Health | 2.33% | $1.85M | $8.68B | 219.32% | 51 Neutral | |
| NeoGenomics | 2.26% | $1.79M | $1.28B | -26.63% | 53 Neutral | |
| BrightSpring Health Services, Inc. | 2.25% | $1.78M | $6.16B | 113.70% | 67 Neutral | |
| HCA Healthcare | 2.21% | $1.75M | $109.15B | 29.33% | 77 Outperform | |
| Universal Health | 2.14% | $1.70M | $13.95B | 6.51% | 78 Outperform | |
| McKesson | 2.14% | $1.70M | $100.08B | 61.18% | 74 Outperform | |
| Brookdale Senior Living | 2.14% | $1.69M | $2.10B | 41.05% | 60 Neutral | |
| Radnet | 2.13% | $1.69M | $6.10B | 16.84% | 66 Neutral | |
| Select Medical | 2.13% | $1.68M | $1.76B | -57.09% | 74 Outperform |
XHS Technical Analysis
Positive
―
Price Trends
100.60
Positive
97.45
Positive
97.50
Positive
Market Momentum
1.42
Negative
63.03
Neutral
77.53
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XHS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 102.89, equal to the 50-day MA of 100.60, and equal to the 200-day MA of 97.50, indicating a bullish trend. The MACD of 1.42 indicates Negative momentum. The RSI at 63.03 is Neutral, neither overbought nor oversold. The STOCH value of 77.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XHS.
XHS Peer Comparison
Comparison Results
Performance Comparison
XHS
SPDR S&P Health Care Services ETF
104.77
11.46
12.28%
SBIO
ALPS Medical Breakthroughs ETF
―
―
―
LFSC
F/M Emerald Life Sciences Innovation ETF
―
―
―
IBBQ
Invesco Nasdaq Biotechnology ETF
―
―
―
BBP
Virtus LifeSci Biotech Products ETF
―
―
―
BBC
Virtus LifeSci Biotech Clinical Trials ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents